Suggested application of HER2+ breast tumor phenotype for germline TP53 variant classification within ACMG/AMP guidelines

Cristina Fortuno, Jessica Mester, Tina Pesaran, MA, MS, CGC, Jeffrey N Weitzel, Jill Dolinsky, Amal Yussuf, Kelly McGoldrick, Judy E. Garber, Sharon A Savage, Payal P Khincha, D. Gareth Evans, Maria Isabel Achatz, Kim E Nichols, Kara N. Maxwell, Joshua D. Schiffman, Renata Sandoval, Paul A. James, Amanda B. Spurdle